PillRx only · Capsule, Gelatin Coated · Oral
Tacrolimus
Brands: Prograf · Tacrolimus
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$7.927
Latest avg · Jul 22, 2026
-78%
Since Jan 22, 2025
3
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
3.3K
Rx · 2026 Q1
339K
Units dispensed
-17%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Panacea Biotec Limited | unknown | 3 | SUPPLYING |
| Jubilant Cadista Pharmaceuticals Inc. | unknown | 3 | SUPPLYING |
| Astellas Pharma US, Inc. | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 23, 2024RECALLRecall (Class I): Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharm…
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules — Recalling firm: Astellas Pharma US Inc. — Nationwide in the USA